# Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion

> **NCT00808665** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 68 (actual)

## Conditions studied

- Spinal Fusion Acquired
- Spinal Stenosis
- Lesions of Lumbosacral Intervertebral Disc
- Spinal Diseases

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** 0.9% Saline

## Key facts

- **NCT ID:** NCT00808665
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00808665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00808665, "Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00808665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*